Asahi Kasei Ventures took part in a $70m round for food waste technology provider Hazel Technologies while Zoll Medical Corporation bought portfolio company Respicardia.

Funding Hazel Technologies, a US-based anti-food waste technology developer, said it has completed documentation for a $70m series C round featuring Asahi Kasei Ventures, the investment arm of chemicals producer Asahi Kasei. The round was co-led by Pontifax AgTech and Temasek, and included S2G Ventures, Pangaea Ventures, Rhapsody Venture Partners, Jordan Park Group and Jeremy…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.